Bob Geng, M.D.

Bio

Dr. Bob Geng is an allergist/immunologist at Rady Children's Hospital-San Diego and an assistant clinical professor at UC San Diego School of Medicine.

Dr. Geng earned his bachelors and masters degrees from Georgetown University. He then received his medical degree and residency training at Washington University School of Medicine in St. Louis before completing a fellowship in allergy and immunology at UC Los Angeles. He is board certified in internal medicine, allergy and immunology and clinical pharmacology.

Dr. Geng sees both pediatric and adult patients for allergic and immunologic conditions. He has a special interest in allergic conditions of the upper and lower airways as well as primary immunodeficiency disorders in both children and adults. In addition to general allergy clinics, he currently has a monthly immunology clinic focusing on primary immunodeficiency as well as a monthly Severe Asthma Clinic focusing on difficult-to-manage pediatric asthma patients.

Given his background in clinical pharmacology, Dr. Geng has an interest in clinical research, particularly in bringing novel and advanced therapies to children with allergic and immunologic disorders. He is currently conducting several clinical trials in moderate to severe asthma and primary immunodeficiency. Please contact him if you have any interest in having your child participate in any clinical studies.

Publications

Plain language summary: Headache and migraine experiences in people with primary immunodeficiency receiving GAMMAPLEX® 5% or 10% intravenous immunoglobulin therapy.
Geng B, Clark K

Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies.
Blauvelt A, Kircik L, Simpson EL, Lio P, Eichenfield LF, Prajapati VH, Grewal P, Lynde C, Hong HC, Sturm D, Kallender H, Ren H, Paranagama D, Wong GKW, Geng B

Impact of type 2-targeted therapies on respiratory infection risk.
Smiley K, Zuhdi N, Geng B

Comparative single-cell lineage bias in human and murine hematopoietic stem cells.
Shamie I, Bliss-Moreau M, Lee JC, Mathieu R, Hoffman HM, Geng B, Lewis NE, Zhu YP, Croker BA

Dual dysregulation of TNF/interferon signaling and classical monocytes are implicated in Reactive Infectious Mucocutaneous Eruptions.
Tan Z, Wu G, Salgado Figueroa D, Dutta P, Jaeger Z, Mazurie M, Schairer D, Eichenfield D, Tom WL, Galli L, Eichenfield L, Geng B, Hinds B, Hoffman HM, Broderick L, Croker B, Ay F, Oldenburg R

Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis?
Simpson EL, Silverberg JI, Geng B, Carrascosa JM, Bieber T, Brunner PM, Staumont-Sallé D, Ji C, Biswas P, Feeney C, Hernández-Martín I, Rebollo Laserna FJ, Koppensteiner H

Effect of tralokinumab on moderate-to-severe atopic dermatitis in patients with atopic comorbidities.
Paller AS, Soong W, Boguniewicz M, Geng B, Thyssen JP, Bennike N, Schneider S, Wollenberg A

Long-Term Safety of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: Integrated Analysis by Age.
Cork MJ, Deleuran M, Geng B, Silverberg JI, Simpson EL, Stein Gold LF, Irvine AD, Romero W, Valdez H, Fan H, Alderfer J

Multi-Year Registry Study of Elapegademase Treatment in Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Therapy.
Dorsey MJ, Butte MJ, Lieberman JA, Lehman H, Fausnight T, Keller MD, Fradette C, Hershfield MS, Pozos TC, Rozova A, Wall LA, Bednarski JJ, Tarrant TK, Chong HJ, Geng B, Temin NT, Laubach SS, Lin L, Mousallem T, Walter JE

Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study.
Magnolo N, Cameron MC, Shahriari M, Geng B, Calimlim BM, Teixeira H, Hu X, Yang Y, Liu Y, Zhang S, Sancho Sanchez C, Altman K, Langley RG

The role of OX40 ligand/OX40 axis signalling in atopic dermatitis.
Guttman-Yassky E, Croft M, Geng B, Rynkiewicz N, Lucchesi D, Peakman M, van Krinks C, Valdecantos W, Xing H, Weidinger S

From Research to Practice: The Latest Data on Evolving Treatments for Chronic Spontaneous Urticaria.
Gooderham MJ, Kwatra SG, Geng B

Corrigendum: Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency.
Geng B, Clark K, Evangelista M, Wolford E

Multidisciplinary atopic dermatitis program: A novel approach to managing difficult-to-control atopic dermatitis patients.
Tracy A, Loop L, Bhatti S, Anterasian C, Kellogg C, Smiley K, Wu A, Geng B, Eichenfield L

Implementation of a pediatric synchronous multidisciplinary severe asthma clinic and real-world outcomes.
Patel D, Revier MD, Tambay A, Geng B

Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency.
Geng B, Clark K, Evangelista M, Wolford E

Rapid genome sequencing identifies novel variants in complement factor I.
Rodriguez KM, Vaught J, Dilley M, Ellsworth K, Heinen A, Abud EM, Zhang Y, Smith RJH, Sheets R, Geng B, Hoffman HM, Worthen HM, Dimmock D, Coufal NG

Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig(®)]) in the treatment of patients with primary immunodeficiencies.
Kobayashi RH, Gupta S, Melamed I, Mandujano JF, Kobayashi AL, Ritchie B, Geng B, Atkinson TP, Rehman S, Turpel-Kantor E, Litzman J

Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies.
Kobayashi RH, Litzman J, Melamed I, Mandujano JF, Kobayashi AL, Ritchie B, Geng B, Atkinson TP, Rehman S, Höller S, Turpel-Kantor E, Kreuwel H, Speer JC, Gupta S

A novel case of chronic spontaneous urticaria associated chronic myelogenous leukemia with rapid resolution upon treatment with imatinib.
Tracy A, Kahn J, Geng B, Russo M, Safai B

Allergen Content and Protease Activity in Milk Feeds from Mothers of Preterm Infants.
Luskin K, Mortazavi D, Bai-Tong S, Bertrand K, Chambers C, Schulkers-Escalante K, Ahmad A, Luedtke S, O'Donoghue AJ, Ghassemian M, Geng B, Leibel SL, Leibel SA

Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.
Geier CB, Ellison M, Cruz R, Pawar S, Leiss-Piller A, Zmajkovicova K, McNulty SM, Yilmaz M, Evans MO 2nd, Gordon S, Ujhazi B, Wiest I, Abolhassani H, Aghamohammadi A, Barmettler S, Bhar S, Bondarenko A, Bolyard AA, Buchbinder D, Cada M, Cavieres M, Connelly JA, Dale DC, Deordieva E, Dorsey MJ, Drysdale SB, Ehl S, Elfeky R, Fioredda F, Firkin F, Förster-Waldl E, Geng B, Goda V, Gonzalez-Granado L, Grunebaum E, Grzesk E, Henrickson SE, Hilfanova A, Hiwatari M, Imai C, Ip W, Jyonouchi S, Kanegane H, Kawahara Y, Khojah AM, Kim VH, Kojić M, Kołtan S, Krivan G, Langguth D, Lau YL, Leung D, Miano M, Mersyanova I, Mousallem T, Muskat M, Naoum FA, Noronha SA, Ouederni M, Ozono S, Richmond GW, Sakovich I, Salzer U, Schuetz C, Seeborg FO, Sharapova SO, Sockel K, Volokha A, von Bonin M, Warnatz K, Wegehaupt O, Weinberg GA, Wong KJ, Worth A, Yu H, Zharankova Y, Zhao X, Devlin L, Badarau A, Csomos K, Keszei M, Pereira J, Taveras AG, Beaussant-Cohen SL, Ong MS, Shcherbina A, Walter JE

Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma.
Wangberg H, Mortazavi D, Kitsen J, Sanni A, Leibel S, Geng B

Mepolizumab prefilled syringe for the treatment of severe eosinophilic asthma: focus on the pediatric population.
Revier MD, Geng B

Atopic dermatitisReview of comorbidities and therapeutics.
Appiah MM, Haft MA, Kleinman E, Laborada J, Lee S, Loop L, Geng B, Eichenfield LF

See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.

PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.